Show simple item record

dc.contributor.authorOmonaiye, O
dc.contributor.authorNicholson, P
dc.contributor.authorKusljic, S
dc.contributor.authorMohebbi, M
dc.contributor.authorManias, E
dc.date.accessioned2020-12-08T00:07:02Z
dc.date.available2020-12-08T00:07:02Z
dc.date.issued2020-11-01
dc.identifierpii: S0149-2918(20)30420-3
dc.identifier.citationOmonaiye, O., Nicholson, P., Kusljic, S., Mohebbi, M. & Manias, E. (2020). Medication-based Refill Adherence Among Pregnant Women Living With HIV in Nigeria. CLINICAL THERAPEUTICS, 42 (11), pp.E209-E219. https://doi.org/10.1016/j.clinthera.2020.08.014.
dc.identifier.issn0149-2918
dc.identifier.urihttp://hdl.handle.net/11343/252870
dc.description.abstractPURPOSE: A major global public health challenge is the continuance of new pediatric HIV infections primarily because of mother to child transmission of HIV occurring mainly in sub-Saharan African countries. The purpose of this study was to examine antiretroviral therapy (ART) refill adherence and its determinants among pregnant women living with HIV in Nigeria. METHODS: A retrospective review of pharmacy refill records was undertaken to examine adherence data on 275 pregnant women undergoing ART in 4 high-volume HIV treatment sites in Nigeria. A pharmacy refill adherence measure was used to assess medication refill behavior of pregnant women living with HIV who had received an ART refill during a period of 3 months. Medication-based ART refill adherence was categorized as % adherence (100% adherence) or % nonadherence (<100% adherence) to the ART refill scheduled dates. Refill appointments were scheduled on a 28-day cycle. Multivariable logistic regression analysis was performed. FINDINGS: Of the 275 women, 59.3% (95% CI, 53.1%-65.5%) were adherent to their ART refill schedule. Women who initiated ART during the third trimester of their current pregnancy had the lowest adherence rate of 30.8% (95% CI, 7.7%-53.8%) compared with women who commenced ART before conception or during the first or second trimester. The availability of a treatment support person was significantly associated with ART refill adherence. The odds of medication-based refill adherence were 2.9 times higher for participants who had a treatment support person (odds ratio = 2.9; 95% CI, 1.6-5.2; p = 0.001). IMPLICATIONS: Results indicate that having a treatment support person could contribute to improving ART adherence in pregnant women living in Nigeria.
dc.languageEnglish
dc.publisherELSEVIER
dc.titleMedication-based Refill Adherence Among Pregnant Women Living With HIV in Nigeria
dc.typeJournal Article
dc.identifier.doi10.1016/j.clinthera.2020.08.014
melbourne.affiliation.departmentNursing
melbourne.source.titleClinical Therapeutics: the international peer-reviewed journal of drug therapy
melbourne.source.volume42
melbourne.source.issue11
melbourne.source.pagesE209-E219
melbourne.elementsid1466162
melbourne.contributor.authorKusljic, Snezana
melbourne.contributor.authorManias, Elizabeth
dc.identifier.eissn1879-114X
melbourne.accessrightsThis item is currently not available from this repository


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record